Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,047.72
(
-0.13%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: MotionMan post# 89870

Friday, 01/29/2010 9:04:49 PM

Friday, January 29, 2010 9:04:49 PM

Post# of 257580

I hope management will shed some light on possible approval time frame at quarterly conference call.

There is nothing management can say beyond what’s already been said: MNTA and NVS have done everything that’s been requested and the ball is in the FDA’s court.

Does anyone know when that is happening?

Probably on Feb 11. Also, MNTA is presenting at the BioCEO conference on Feb 8:

http://finance.yahoo.com/news/Momenta-Pharmaceuticals-to-pz-2780709024.html?x=0&.v=1


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today